REQUEST A DEMO
Total
USD $0.00
Search more companies

Symgens Company Limited (Thailand)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Symgens Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Symgens Company Limited is an enterprise located in Thailand, with the main office in Bangkok , Special Governed District of. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on June 01, 2026. 37 (estimated) employees currently work for Symgens Company Limited. From the latest financial highlights, Symgens Company Limited reported a net sales revenue increase of 22.57% in 2024. A growth of 31.84% was recorded in its total assets. The net profit margin of Symgens Company Limited decreased by 0.07% in 2024.

Headquarters
1/102 Soi Ngam Wong Wan 43 Yeak 2-1 ( Chinkhet1/21)
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10210

Contact Details: Purchase the Symgens Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Symgens Company Limited report to view the information.
Financial Auditors:
Purchase the Symgens Company Limited report to view the information.
Incorporation Date:
June 01, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Symgens Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
22.57%
Total Operating Revenue
23.5%
Operating Profit
25.51%
EBITDA
25.51%
Net Profit/Loss for the Period
21.85%
Total Assets
31.84%
Total Equity
23.79%
Operating Profit Margin
0.36%
Net Profit Margin
-0.07%
Return on Equity (ROE)
-0.3%
Debt / Equity
8.48%
Quick Ratio
0.03%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?